Cornerstone Directors Can't Escape Suit Over $255M Buyout
A Delaware Chancery Court judge on Wednesday left mostly intact a consolidated suit by Cornerstone Therapeutics Inc. investors challenging the fairness of Chiesi Farmaceutici SpA's $255 million buyout of the company,...To view the full article, register now.
Already a subscriber? Click here to view full article